{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:41:35Z","timestamp":1793256095258,"version":"4.5.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R37 AI050234, R01 AI124678, R01 AI147628"],"award-info":[{"award-number":["R37 AI050234, R01 AI124678, R01 AI147628"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R21 AI159558"],"award-info":[{"award-number":["R21 AI159558"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["F31 AI157410"],"award-info":[{"award-number":["F31 AI157410"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K08 AI163497"],"award-info":[{"award-number":["K08 AI163497"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 AI182318"],"award-info":[{"award-number":["R01 AI182318"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"L. M. H."},{"name":"Columbia University Graduate Program"},{"name":"Microbiology and Immunology"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32 AI106711"],"award-info":[{"award-number":["T32 AI106711"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Doris Duke Physician Scientist"},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["2019121"],"award-info":[{"award-number":["2019121"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Human Frontiers Science Program Long-Term Fellowship","award":["LT000976\/2016-L"],"award-info":[{"award-number":["LT000976\/2016-L"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Piperaquine, used in combination with dihydroartemisinin, has been identified as a promising partner drug for uncomplicated treatment and chemoprevention of Plasmodium falciparum malaria in Africa. In light of the earlier spread of piperaquine resistance in Southeast Asia, mediated primarily by mutations in the drug efflux transporter PfCRT, we have explored whether PfCRT mutations would represent a probable path to piperaquine resistance becoming established in Africa.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We edited PfCRT mutations known to mediate piperaquine resistance in Southeast Asia into P falciparum asexual blood-stage parasites expressing 3 prevalent African mutant PfCRT haplotypes. Gene-edited clones were profiled in antimalarial concentration-response and competitive fitness assays.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>pfcrt-edited parasites expressing the contemporary Southeast Asian T93S or I218F mutations added to the GB4 and Cam783 haplotypes common in Africa did not mediate piperaquine resistance, with partial survival only at low drug concentrations. In contrast, parasites expressing these mutations on the rare PfCRT FCB haplotype, observed mostly in Northeast Africa, acquired a moderate level of piperaquine resistance. Dd2GB4, Dd2Cam783, and Dd2FCB lines edited to express the T93S or I218F mutations showed increased susceptibility to chloroquine. Piperaquine-resistant African PfCRT isoforms conferred a substantial fitness cost, manifesting as reduced asexual blood-stage parasite growth rates.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These findings suggest that piperaquine-resistant PfCRT mutations that emerged in Southeast Asia mediate resistance only in a limited subset of African PfCRT haplotypes, with fitness costs that we suspect would likely preclude dissemination in high-transmission malaria-endemic African regions.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiae617","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T22:25:12Z","timestamp":1733955912000},"page":"e976-e985","source":"Crossref","is-referenced-by-count":7,"title":["<i>Plasmodium falciparum<\/i> African PfCRT Mutant Isoforms Conducive to Piperaquine Resistance Are Infrequent and Impart a Major Fitness Cost"],"prefix":"10.1093","volume":"231","author":[{"given":"Laura M","family":"Hagenah","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology"},{"name":"Center for Malaria Therapeutics and Antimicrobial Resistance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Yeo","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology"},{"name":"Center for Malaria Therapeutics and Antimicrobial Resistance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4406-9160","authenticated-orcid":false,"given":"Kyra A","family":"Schindler","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology"},{"name":"Center for Malaria Therapeutics and Antimicrobial Resistance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin H","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology"},{"name":"Center for Malaria Therapeutics and Antimicrobial Resistance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8613-0457","authenticated-orcid":false,"given":"Talia S","family":"Bloxham","sequence":"additional","affiliation":[{"name":"Center for Malaria Therapeutics and Antimicrobial Resistance"},{"name":"Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center , New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L","family":"Small-Saunders","sequence":"additional","affiliation":[{"name":"Center for Malaria Therapeutics and Antimicrobial Resistance"},{"name":"Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center , New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachel","family":"Mok","sequence":"additional","affiliation":[{"name":"Center for Malaria Therapeutics and Antimicrobial Resistance"},{"name":"Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center , New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6753-8938","authenticated-orcid":false,"given":"David A","family":"Fidock","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology"},{"name":"Center for Malaria Therapeutics and Antimicrobial Resistance"},{"name":"Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center , New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"2025060208124824600_jiae617-B1","doi-asserted-by":"crossref","DOI":"10.30875\/9789287076717","volume-title":"World malaria report 2024","author":"World Health Organization","year":"2024"},{"key":"2025060208124824600_jiae617-B2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4269\/ajtmh.2001.64.12","article-title":"The public health impact of chloroquine resistance in Africa","volume":"64","author":"Trape","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"2025060208124824600_jiae617-B3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.1155165","article-title":"Qinghaosu (artemisinin): the price of success","volume":"320","author":"White","year":"2008","journal-title":"Science"},{"key":"2025060208124824600_jiae617-B4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"2025060208124824600_jiae617-B5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"2025060208124824600_jiae617-B6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"2025060208124824600_jiae617-B7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1473-3099(15)70049-6","article-title":"Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study","volume":"15","author":"Spring","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2025060208124824600_jiae617-B8","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2025060208124824600_jiae617-B9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12916-015-0539-5","article-title":"Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations","volume":"13","author":"Duru","year":"2015","journal-title":"BMC Med"},{"key":"2025060208124824600_jiae617-B10","doi-asserted-by":"crossref","first-page":"e00303-17","DOI":"10.1128\/mBio.00303-17","article-title":"A variant PfCRT isoform can contribute to Plasmodium falciparum resistance to the first-line partner drug piperaquine","volume":"8","author":"Dhingra","year":"2017","journal-title":"mBio"},{"key":"2025060208124824600_jiae617-B11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/infdis\/jix334","article-title":"Association of a novel mutation in the Plasmodium falciparum chloroquine resistance transporter with decreased piperaquine sensitivity","volume":"216","author":"Agrawal","year":"2017","journal-title":"J Infect Dis"},{"key":"2025060208124824600_jiae617-B12","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1038\/s41467-018-05652-0","article-title":"Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine","volume":"9","author":"Ross","year":"2018","journal-title":"Nat Commun"},{"key":"2025060208124824600_jiae617-B13","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S1473-3099(19)30543-2","article-title":"Plasmodium falciparum resistance to piperaquine driven by PfCRT","volume":"19","author":"Dhingra","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2025060208124824600_jiae617-B14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","article-title":"A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study","volume":"17","author":"Witkowski","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2025060208124824600_jiae617-B15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","article-title":"Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study","volume":"17","author":"Amato","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2025060208124824600_jiae617-B16","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/s41467-018-04104-z","article-title":"Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum","volume":"9","author":"Bopp","year":"2018","journal-title":"Nat Commun"},{"key":"2025060208124824600_jiae617-B17","doi-asserted-by":"crossref","first-page":"eadi2364","DOI":"10.1126\/sciadv.adi2364","article-title":"Mapping the genomic landscape of multidrug resistance in Plasmodium falciparum and its impact on parasite fitness","volume":"9","author":"Mok","year":"2023","journal-title":"Sci Adv"},{"key":"2025060208124824600_jiae617-B18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-019-1795-x","article-title":"Structure and drug resistance of the Plasmodium falciparum transporter PfCRT","volume":"576","author":"Kim","year":"2019","journal-title":"Nature"},{"key":"2025060208124824600_jiae617-B19","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1021\/acs.biochem.0c00247","article-title":"Altered drug transport by Plasmodium falciparum chloroquine resistance transporter isoforms harboring mutations associated with piperaquine resistance","volume":"59","author":"Riegel","year":"2020","journal-title":"Biochemistry"},{"key":"2025060208124824600_jiae617-B20","doi-asserted-by":"crossref","first-page":"e1011436","DOI":"10.1371\/journal.ppat.1011436","article-title":"PfCRT mutations conferring piperaquine resistance in falciparum malaria shape the kinetics of quinoline drug binding and transport","volume":"19","author":"Gomez","year":"2023","journal-title":"PLoS Pathog"},{"key":"2025060208124824600_jiae617-B21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41467-019-08297-9","article-title":"Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children","volume":"10","author":"Chotsiri","year":"2019","journal-title":"Nat Commun"},{"key":"2025060208124824600_jiae617-B22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12936-021-03873-1","article-title":"Efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria among children in Africa: a systematic review and meta-analysis of randomized control trials","volume":"20","author":"Assefa","year":"2021","journal-title":"Malar J"},{"key":"2025060208124824600_jiae617-B23","doi-asserted-by":"crossref","first-page":"e0264339","DOI":"10.1371\/journal.pone.0264339","article-title":"Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa: a systematic review and meta-analysis","volume":"17","author":"Marwa","year":"2022","journal-title":"PLoS One"},{"key":"2025060208124824600_jiae617-B24","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/infdis\/jiac365","article-title":"Mutant PfCRT can mediate piperaquine resistance in African Plasmodium falciparum with reduced fitness and increased susceptibility to other antimalarials","volume":"226","author":"Wicht","year":"2022","journal-title":"J Infect Dis"},{"key":"2025060208124824600_jiae617-B25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1473-3099(23)00564-9","article-title":"Determinants of piperaquine-resistant malaria in South America","volume":"24","author":"Mok","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025060208124824600_jiae617-B26","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1096\/fj.11-187401","article-title":"Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches","volume":"25","author":"Ekland","year":"2011","journal-title":"FASEB J"},{"key":"2025060208124824600_jiae617-B27","doi-asserted-by":"crossref","first-page":"e1005976","DOI":"10.1371\/journal.ppat.1005976","article-title":"Evolution of fitness cost-neutral mutant PfCRT conferring P. falciparum 4-aminoquinoline drug resistance is accompanied by altered parasite metabolism and digestive vacuole physiology","volume":"12","author":"Gabryszewski","year":"2016","journal-title":"PLoS Pathog"},{"key":"2025060208124824600_jiae617-B28","doi-asserted-by":"crossref","first-page":"e66277","DOI":"10.7554\/eLife.66277","article-title":"Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness","volume":"10","author":"Stokes","year":"2021","journal-title":"Elife"},{"key":"2025060208124824600_jiae617-B29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.12688\/wellcomeopenres.16168.1","article-title":"An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples","volume":"6","author":"Ahouidi","year":"2021","journal-title":"Wellcome Open Res"},{"key":"2025060208124824600_jiae617-B30","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","article-title":"Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine","volume":"91","author":"Venkatesan","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"2025060208124824600_jiae617-B31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nyas.12766","article-title":"Antimalarial drug resistance in Africa: key lessons for the future","volume":"1342","author":"Takala-Harrison","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"2025060208124824600_jiae617-B32","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/molbev\/msw037","article-title":"Combinatorial genetic modeling of pfcrt-mediated drug resistance evolution in Plasmodium falciparum","volume":"33","author":"Gabryszewski","year":"2016","journal-title":"Mol Biol Evol"},{"key":"2025060208124824600_jiae617-B33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"2025060208124824600_jiae617-B34","doi-asserted-by":"crossref","first-page":"e1010278","DOI":"10.1371\/journal.ppat.1010278","article-title":"Evidence for the early emergence of piperaquine-resistant Plasmodium falciparum malaria and modeling strategies to mitigate resistance","volume":"18","author":"Small-Saunders","year":"2022","journal-title":"PLoS Pathog"},{"key":"2025060208124824600_jiae617-B35","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1038\/s41467-020-17781-6","article-title":"The natural function of the malaria parasite's chloroquine resistance transporter","volume":"11","author":"Shafik","year":"2020","journal-title":"Nat Commun"},{"key":"2025060208124824600_jiae617-B36","doi-asserted-by":"crossref","first-page":"e0110122","DOI":"10.1128\/spectrum.01101-22","article-title":"The knock-down of the chloroquine resistance transporter PfCRT is linked to oligopeptide handling in Plasmodium falciparum","volume":"10","author":"Sanchez","year":"2022","journal-title":"Microbiol Spectr"},{"key":"2025060208124824600_jiae617-B37","doi-asserted-by":"crossref","first-page":"e1010926","DOI":"10.1371\/journal.ppat.1010926","article-title":"Piperaquine-resistant PfCRT mutations differentially impact drug transport, hemoglobin catabolism and parasite physiology in Plasmodium falciparum asexual blood stages","volume":"18","author":"Okombo","year":"2022","journal-title":"PLoS Pathog"},{"key":"2025060208124824600_jiae617-B38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng.3189","article-title":"Genetic architecture of artemisinin-resistant Plasmodium falciparum","volume":"47","author":"Miotto","year":"2015","journal-title":"Nat Genet"},{"key":"2025060208124824600_jiae617-B39","doi-asserted-by":"crossref","first-page":"e02731-18","DOI":"10.1128\/mBio.02731-18","article-title":"Global spread of mutant PfCRT and its pleiotropic impact on Plasmodium falciparum multidrug resistance and fitness","volume":"10","author":"Dhingra","year":"2019","journal-title":"mBio"},{"key":"2025060208124824600_jiae617-B40","doi-asserted-by":"crossref","first-page":"e00374-18","DOI":"10.1128\/AAC.00374-18","article-title":"Absence of a high level of duplication of the plasmepsin II gene in Africa","volume":"62","author":"Robert","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2025060208124824600_jiae617-B41","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/infdis\/jiaa687","article-title":"Changing prevalence of potential mediators of aminoquinoline, antifolate, and artemisinin resistance across Uganda","volume":"223","author":"Asua","year":"2021","journal-title":"J Infect Dis"},{"key":"2025060208124824600_jiae617-B42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(23)00502-9","article-title":"Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in the Guianas: a descriptive epidemiological study","volume":"24","author":"Florimond","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2025060208124824600_jiae617-B43","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/cmdc.202000895","article-title":"Malaria pigment crystals: the Achilles\u2019 heel of the malaria parasite","volume":"16","author":"Kapishnikov","year":"2021","journal-title":"ChemMedChem"},{"key":"2025060208124824600_jiae617-B44","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.celrep.2019.10.095","article-title":"Decreased K13 abundance reduces hemoglobin catabolism and proteotoxic stress, underpinning artemisinin resistance","volume":"29","author":"Yang","year":"2019","journal-title":"Cell Rep"},{"key":"2025060208124824600_jiae617-B45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1126\/science.aax4735","article-title":"A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites","volume":"367","author":"Birnbaum","year":"2020","journal-title":"Science"},{"key":"2025060208124824600_jiae617-B46","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/mmi.12349","article-title":"The interplay between drug resistance and fitness in malaria parasites","volume":"89","author":"Rosenthal","year":"2013","journal-title":"Mol Microbiol"},{"key":"2025060208124824600_jiae617-B47","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/mmi.13035","article-title":"Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter","volume":"97","author":"Petersen","year":"2015","journal-title":"Mol Microbiol"},{"key":"2025060208124824600_jiae617-B48","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/522154","article-title":"Seasonal carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum imply reduced fitness of chloroquine-resistant parasites","volume":"196","author":"Ord","year":"2007","journal-title":"J Infect Dis"},{"key":"2025060208124824600_jiae617-B49","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1073\/pnas.0804628105","article-title":"Benefits of using multiple first-line therapies against malaria","volume":"105","author":"Boni","year":"2008","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiae617\/61052411\/jiae617.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/231\/5\/e976\/61052411\/jiae617.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/231\/5\/e976\/61052411\/jiae617.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:13:02Z","timestamp":1748866382000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/231\/5\/e976\/7921486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,12,11]]},"published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiae617","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5,15]]},"published":{"date-parts":[[2024,12,11]]}}}